Sobańska, N. (2023) “Gliflozins and their beneficial hypoglycaemic effect profile and prevention of cardiovascular complications in patients treated for type II diabetes mellitus”, Quality in Sport, 9(2), pp. 11–17. doi: 10.12775/QS.2023.09.02.001.